ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0007095;mitotic G2 DNA damage checkpoint;11.0;1.0;0.9324289523296623;9.628524252492122;857.7571147403349;6.7325511899570465;0.028708358699073767;0.7767319332797141;[MSH6, FANCI, BLM, DONSON, CDK1, TOPBP1]
GO:0006284;base-excision repair;8.0;0.9326813400603323;0.8413406700301662;9.584072489921288;183.0506323445446;5.69953618377475;0.006126539929698291;0.6664745454937787;[UNG, LIG1, HMGA1, RPA1, RPA3]
GO:0007098;centrosome cycle;4.0;1.0;0.75;9.628524252492122;37.692070457630365;6.088194173566533;0.0012615196775557923;0.5613505331661754;[PPP1R12A, PLK1, HEPACAM2, TUBE1, BRCA1, UXT, FES, NUP62, CDK1]
GO:0007131;reciprocal meiotic recombination;9.0;1.0;0.896240625180289;9.628524252492122;175.07189671554147;6.343086423195323;0.005859498828591432;0.7206263598461826;[RAD54B, RAD50, RAD51, RAD51C]
GO:0006283;transcription-coupled nucleotide-excision repair;9.0;1.0;0.896240625180289;9.628524252492122;184.43692670566384;5.486614186532078;0.006172937954381027;0.676826329833192;[CCNH, RFC5, RFC3, RFC4, RFC1, LIG1, RFC2, PCNA, POLD3, POLD1, POLR2E, POLR2I, POLR2J, POLR2K, POLR2L, RPA1, GTF2H1, COPS5, RPA3]
GO:0006289;nucleotide-excision repair;8.0;0.8436909121759173;0.7968454560879586;9.461470167828956;183.0506323445446;5.132682728539097;0.006126539929698291;0.6374856334316459;[CCNH, BRCA2, RFC5, RFC3, RFC4, RFC1, LIG1, RFC2, SIRT1, PCNA, POLD3, POLD1, RBBP8, POLR2E, POLR2I, POLR2J, POLR2K, POLR2L, RPA1, GTF2H1, COPS5, RPA3]
GO:0042771;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;8.0;1.0;0.875;9.628524252492122;164.97679920792456;6.409777797693995;0.005521625000009403;0.7027963346592216;[CDKN1A, BRCA2, SIRT1, PYCARD, MSH2]
GO:0008585;female gonad development;5.0;1.0;0.7902410118609202;9.628524252492122;50.96471695749156;6.8867018697843045;0.001705743211299806;0.6424272657460779;[NUP107, BRCA2]
GO:0006287;base-excision repair, gap-filling;7.0;1.0;0.8509193652572005;9.628524252492122;149.0421272461911;8.16763571524637;0.0049883058697239;0.7686126355688037;[POLD1]
GO:0045004;DNA replication proofreading;8.0;1.0;0.875;9.628524252492122;333.70219750316977;9.083926447120524;0.011168712237951276;0.839552420951524;[POLD1]
GO:0045766;positive regulation of angiogenesis;7.0;0.811012628672052;0.7564256795932265;9.303101852057495;134.49314513679974;4.7081694254602375;0.0045013645317563845;0.5916953686275062;[NRP1, ECM1, CD40, SERPINE1, ITGB2, ADM, BRCA1, AQP1, CDH5, C3AR1, CTSH, CYP1B1, ITGB8, CD34, IL10, GHSR, ANXA1, ANXA3, GAB1, SIRT1, F3, GREM1, SFRP2, IL1B, ADAM12, AGTR1, CHI3L1, ENG, CX3CR1, C5AR1, TWIST1, PTGS2, DLL1, THBS1, CXCR2, HMOX1, PLCG1, JUP, PLK2, TNFSF12, KLF4, LRG1, TEK]
GO:0051090;regulation of DNA binding transcription factor activity;10.0;0.7192862368539868;0.7748841302879137;9.223059144383958;255.33763090554476;3.793137346993279;0.00854592071745993;0.6092222321850824;[PHB2, AKT1, TNFSF11, CYP1B1, SFRP4, BTK, SIK1, PRKCQ, BEX1, TWIST1, PKHD1, NHLH2, S100A12, HMOX1, FZD1, JUN, JUP, ID1, EZH2, CD40, CD36, HAVCR2, IL10, EDN1, SYK, ANXA3, NFAM1, FOS, SIRT1, PSMA6, HCK, IL1B, KIT, TLR6, SGK1, TLR4, TLR2, FLNA, POU4F1, NLRP12, CD40LG, TNF, CLU, PYCARD, MEN1, FANCD2, S100A8, CARD11, TNFRSF11A, NLRP3, TGFB1, WFS1, NFKB1, NFKBIA, IL6, COPS5, JMY, CCDC22, MYD88, CREBZF, ITGB2, TNFAIP3, MYOCD, CHUK, IRAK3, TRAF1, GREM1, XCL1, LTF, NLRC4, NOD2, KLF4]
GO:0045892;negative regulation of transcription, DNA-templated;10.0;0.556709148698489;0.6935955862101648;8.520155788878647;1581.2569993850602;2.683669001811703;0.05292324873051003;0.5524839694169422;[SPI1, EHMT2, SLA2, PHB2, MYB, HOXA2, HOXA7, MEF2A, MEF2C, HOXB4, HOXB3, ATF3, GATA3, GATA1, PRDM16, ELANE, FZD1, JUN, PLK1, FZD8, NR2F2, SNAI2, PKIG, EZH2, PAWR, PAX5, SIRT1, PAX2, AES, MMP12, ASCL2, BTAF1, FLNA, NR1H2, POU4F1, CENPF, FOSB, LGR4, GMNN, TNF, DACH1, MEN1, TLE4, FOXO1, NACC2, ZNF423, WFS1, NFKB1, BCL6, CIITA, FHL2, FASLG, HHEX, EMILIN1, RFC1, PEG3, XCL1, BIRC5, RBBP8, E2F1, E2F7, PRRX1, KLF4, KLF8, KLF5, DNAJA3, UXT, ZNF608, EDNRB, DPF3, SOX7, SOX4, RUNX2, EREG, SFRP2, IFI27, TWIST1, PCBP3, EGR1, BCL11A, ID1, SUV39H1, IFNA2, PTPRK, BRCA1, BMI1, XPO1, CD36, EDN1, CBFA2T3, MDFIC, IL1B, DEPDC1, SATB2, PURA, CDX2, ARID4A, LOXL2, CHCHD3, BASP1, CCNE1, CALCA, TGFB1, CBX4, VDR, CAV1, HMGA1, NR4A2, BMP2, NR4A3, MXD1, CREBZF, HMGB2, MYOCD, H2AFX, GREM1, IFNG, ELF3, FBP1, PFDN5, AURKB, SNCA, MEIS2]
GO:0045893;positive regulation of transcription, DNA-templated;10.0;0.5159906454948852;0.673236334608363;8.141425192250265;1208.1179641469014;2.4745772039531437;0.04043462102441837;0.5417910051506925;[PID1, SPI1, SPIB, AKT1, MEF2A, MEF2C, PADI2, ATF3, GATA3, GATA1, JUN, JAG1, JUP, NR2F2, COL1A1, HOXC10, FOS, SIRT1, MMP12, CKS2, STAT4, ATAD2, PSMC6, PSMC2, LGR4, CCNT2, RUVBL2, ADCYAP1, BLM, FOXO1, ZNF423, NFKB1, CXCL10, CIITA, FHL2, HHEX, PPP1R12A, PEG3, E2F1, E2F2, E2F5, E2F7, PRRX1, POU2AF1, CCNH, TNFSF11, SFRP2, EGR1, EGR2, EGR3, CD28, CD40, BRCA1, BRCA2, CD3D, IL10, RGMA, IL1B, YAP1, SATB2, IL17A, CD86, CD80, IHH, CCNE1, VDR, HMGA1, INHBA, IL6, BMP2, TCF4, HMGB2, ARHGEF10L, LYL1, NUP62, YWHAH, MYOCD, ETV1, CCNA2, GREM1, PSRC1, ELF3, CREB5, TAF9, EGF, MAPK14, CD4, RAN, EHF, SERPINE1, MYB, HOXA3, HOXA2, HOXA7, HOXA5, HOXB9, HOXB4, HOXB3, HOXB2, HOXB7, HOXB5, NUP85, PRDM16, NKX2-3, FZD1, NFE2, FZD5, FZD8, TGFB1I1, PAX5, PAX2, ENG, EPCAM, NR1H2, GTF2H1, POU4F1, FOSB, PF4, PLXND1, TNF, CDH1, MEN1, MAP2K2, F2R, COPS5, MAFF, CYR61, LBH, EMILIN1, RFC1, CHUK, TFDP1, SMARCD3, CEBPE, NOD2, ABLIM3, KLF4, KLF1, KLF5, CHEK1, RPS6KA1, DPF3, SOX7, SOX4, SLC11A1, EBF1, FLT3LG, RUNX2, IL23A, BEX1, TWIST1, NHLH2, BCL11B, LIF, TOP2A, IFNA2, PRL, EDN1, RHOG, MDFIC, TLR4, TLR2, CDX2, LILRB1, GRHL2, CAMK4, CAMK1, ARID4A, ARID4B, HOXA11, HOXA10, ADRB2, NLRP3, TGFB2, TGFB1, NR4A2, NFKBIA, NR4A1, NR4A3, SLC40A1, CKAP2, DCN, DNM2, DLL1, LUM, MEIS2, MEIS1, RBMX]
GO:0070200;establishment of protein localization to telomere;8.0;1.0;0.875;9.628524252492122;126.04651321670258;8.16763571524637;0.004218663362865932;0.7926932703116032;[BRCA2]
GO:0032201;telomere maintenance via semi-conservative replication;8.0;0.8933024483968273;0.8216512241984136;9.55953138100517;216.32599304453976;6.7325511899570465;0.0072402363064467505;0.719302980950052;[RFC5, RFC3, FEN1, PCNA, RFC4, RFC1, RFC2, PRIM1, RPA1, POLD3, POLA1, POLA2, POLD1, RPA3]
GO:0071897;DNA biosynthetic process;7.0;0.7090535922965819;0.7054461614054914;9.249034630787218;573.3007402310989;5.058574756385375;0.01918785983836615;0.609615113546532;[BRCA2, CTGF, TK1, RFC5, RFC3, RFC4, RFC1, LIG1, RFC2, SIRT1, DTL, BLM, PCNA, POLD3, POLD1, RPA1, POLA1, POLA2, RAD50, CENPF, POLE2, RPA3]
GO:0010778;meiotic DNA repair synthesis involved in reciprocal meiotic recombination;10.0;1.0;0.9152410118609203;9.628524252492122;603.4248542626775;9.777073627680469;0.020196086825060584;0.9152410118609203;[BRCA2]
GO:0032206;positive regulation of telomere maintenance;8.0;0.7586651285174919;0.754332564258746;9.398000593880289;504.2289052561267;5.8650506222523235;0.0168760876823695;0.6749389615747303;[AURKB, CCT8, CCT7, CCT5, CCT4, CCT3, CCT2, CCT6A, RAD50, PRKCQ]
GO:0034502;protein localization to chromosome;6.0;0.6696747006330769;0.657957662906683;8.489089969303757;32.77360880529348;5.734022359845919;0.001096903192380182;0.6163584827319739;[MIS12, BUB1B, BRCA2, CENPA, AURKB, RUVBL2, PLK1, RPA1, ESCO2, CDK1, EZH2]
GO:0090502;RNA phosphodiester bond hydrolysis, endonucleolytic;8.0;0.6799073451904818;0.7149536725952409;8.878218658092228;231.13671471601307;5.395046993006588;0.007735937832006836;0.6509029541176994;[POP5, FEN1, EXO1, RNASE2]
GO:1902042;negative regulation of extrinsic apoptotic signaling pathway via death domain receptors;10.0;0.9326813400603323;0.8815816818910864;9.589303539338841;425.73912115989816;6.193554689224359;0.014249105244888325;0.731979686697602;[SERPINE1, HMGB2, TNFAIP3, FASLG, BRCA1, HMOX1, DAPK1, TNFRSF10B, SFRP2]
GO:0006296;nucleotide-excision repair, DNA incision, 5'-to lesion;8.0;1.0;0.875;9.628524252492122;115.13879119899096;6.166155715036245;0.0038535917232456105;0.6903374900225189;[PCNA, POLD3, POLD1, RFC5, RFC3, RFC4, RFC1, RFC2, RPA1, GTF2H1, RPA3]
GO:0006293;nucleotide-excision repair, preincision complex stabilization;7.0;1.0;0.8509193652572005;9.628524252492122;108.6814430544141;6.7325511899570465;0.003637470092082656;0.6952223462072524;[RPA1, GTF2H1, RPA3]
GO:1900264;positive regulation of DNA-directed DNA polymerase activity;10.0;1.0;0.9152410118609203;9.628524252492122;1106.254199480119;7.9853141584524145;0.03702533249245755;0.8236103492792612;[RFC5, RFC3, RFC4, RFC2]
GO:0006294;nucleotide-excision repair, preincision complex assembly;7.0;1.0;0.8509193652572005;9.628524252492122;65.90281547005735;6.409777797693995;0.002205707925099542;0.6787156999164222;[CCNH, RPA1, GTF2H1, RPA3]
GO:0007141;male meiosis I;8.0;1.0;0.875;9.628524252492122;140.0657740590801;6.641579411751319;0.004687875406744682;0.7146506799819907;[RAD51C, BRCA2]
GO:0051260;protein homooligomerization;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;42.032160359171186;4.056761851073058;0.00140677858073304;0.5305833023127396;[CDA, KCNG2, TCL1A, TNFSF11, MIF, OLFM4, CLDN3, KCTD12, BLM, MGST1, ACAT1, CD79B, CD79A, NACC2, HMOX1, ECT2, VASP, CAV1, EHD3, CD3G, CD3E, CD3D, ALAD, EMILIN1, TK1, FCER1G, KCND2, VWF, ARG1, NUP54, ACPP, FBP1, COLEC12, NLGN1, HM13, KCNA5, NLRC4, SAMHD1, PLN, GCH1, MARCKS, RAD51, P2RX1, IMPDH2, GOPC, CD247, RBMX]
GO:0006297;nucleotide-excision repair, DNA gap filling;7.0;1.0;0.8509193652572005;9.628524252492122;149.0421272461911;6.641579411751319;0.0049883058697239;0.6905700452391912;[RFC5, RFC3, PCNA, RFC4, RFC1, LIG1, RFC2, RPA1, POLD3, POLD1, RPA3]
GO:0008630;intrinsic apoptotic signaling pathway in response to DNA damage;7.0;0.9326813400603323;0.8172600352873667;9.55953138100517;84.23129647150353;5.54296712308321;0.002819145689655962;0.6343869617060081;[CDKN1A, BCL2A1, BRCA1, BRCA2, TNF, PYCARD, E2F1, HMOX1, SFN, MLH1, TNFRSF1B, SIRT1, MSH6, MSH2, EPHA2]
GO:0006298;mismatch repair;8.0;0.8259837884571596;0.7879918942285797;9.500690880982237;183.0506323445446;6.375876246018314;0.006126539929698291;0.701062607729944;[PCNA, LIG1, RPA1, MLH1, MSH6, POLD3, MSH2, EXO1, RPA3, PMS1]
GO:0042148;strand invasion;7.0;0.8436909121759173;0.7727648213451592;9.456673995565463;149.0421272461911;7.8311634786251565;0.0049883058697239;0.7514054297404357;[RAD51, RAD51C]
GO:0006334;nucleosome assembly;7.0;0.8653626801206646;0.7836007053175329;9.474373572664863;104.51542930890014;4.99795013456894;0.0034980373611892576;0.6065147675675062;[HMGB2, CHAF1B, CHAF1A, RUVBL1, BRD2, H2AFX, PADI4, MCM2, HIST1H2BK, CENPA, H1FX, NASP, CENPH, CENPI, CENPK, CENPL, CENPM, CENPN, CENPO]
GO:0045931;positive regulation of mitotic cell cycle;6.0;0.6073376606709605;0.6267891429256247;8.04155919591008;60.92102604112766;4.779861353916354;0.0020389719162326697;0.5675626445157116;[BRCA2, PHB2, NUP62, PDGFRB, EDN1, ANXA1, CDC25A, EREG, BTC, RAD51C, IL1B, DTL, SMARCD3, CDCA5, TGFA, KCNA5, CCNB1, SH2B1, RANBP2, RANBP1, TGFB1, EGF, UBE2C, CDC6, MEIS2, NDC80, CD28, CDK1, MAD2L1]
GO:0000077;DNA damage checkpoint;8.0;0.811012628672052;0.780506314336026;9.456673995565463;85.75736069739153;5.486614186532078;0.002870221685927797;0.655585704652903;[BLM, CHEK1, E2F1, TOPBP1, FANCI, H2AFX, DONSON, MAPK14, MSH6, MSH2, CDK1]
GO:0071480;cellular response to gamma radiation;7.0;1.0;0.8509193652572005;9.628524252492122;60.39874674087868;6.444869117505266;0.0020214916980741903;0.6805102716434839;[YAP1, EGR1, CDKN1A, H2AFX, NOX4]
GO:0001556;oocyte maturation;4.0;1.0;0.75;9.628524252492122;79.08984218955116;6.8867018697843045;0.0026470658418474595;0.6021862538851576;[CCNB1, FBXO5, BRCA2, EREG]
GO:0031860;telomeric 3' overhang formation;8.0;1.0;0.875;9.628524252492122;149.73527442675106;8.390779266560578;0.005011504882065279;0.8041048419030481;[RAD50]
GO:0050727;regulation of inflammatory response;6.0;0.5272636092234699;0.5867521172018795;7.400047131651798;31.586589572713706;3.8007227183825356;0.00105717472691369;0.517489449159909;[SERPINE1, EDNRB, C3AR1, TNFSF11, IL1R1, IL1R2, PRKCD, IL23A, BTK, AGTR1, GATA3, ADAMTS12, PLA2G7, CD19, S100A12, ELANE, LYN, BST1, CD28, FFAR2, CCR7, CCR2, IL10, ANXA1, FCER1G, IL17RB, PSMA6, HCK, IL1B, TLR10, TLR7, TLR6, TLR4, TLR2, C1QA, PTGS2, NT5E, IGKC, CCL18, CCL23, NLRP12, ZYX, IL17A, PROS1, TNF, CLU, CDH5, IGHG1, GHSR, ADCYAP1, FANCD2, S100A8, SUCNR1, CALCRL, C5AR1, TNFRSF11A, IGLV1-44, NLRP3, SELE, NFKB1, NFKBIA, IL6, BCL6, IGKV3-20, MYD88, TNFAIP6, TNFAIP3, DUSP10, CR2, CR1, TNFRSF1B, LTA, XCL1, NOD2, CNR1, CCL5, CCL4, SNCA, MAPK14, KLF4, CD6, TEK, FCGR2B]
GO:0070317;negative regulation of G0 to G1 transition;7.0;1.0;0.8509193652572005;9.628524252492122;83.03241800612349;6.139487467954083;0.002779020306340262;0.6648930398837374;[EHMT2, BRCA1, BMI1, UXT, CHEK1, RBBP8, E2F1, RRM2, RAD51, TFDP1, EZH2]
GO:0035264;multicellular organism growth;3.0;1.0;0.6981203125901445;9.628524252492122;22.582921643529833;5.382624473008031;7.558300640989654E-4;0.47338797845741154;[IHH, BRCA2, HHEX, SLITRK6, HOXA5, STIL, RMI1, GRHL2, NDUFS6]
GO:0043009;chordate embryonic development;6.0;0.9326813400603323;0.7894609826203107;9.4949928598676;22.496195207419138;4.623782033182691;7.529274083310655E-4;0.5595807407949613;[IHH, EDNRA, PDGFRA, TPM1, MSH2, TWIST1, GATA3, GATA1, EPB41L5, CCNB2, CCNB1, PLCG1, MYH10, STIL, EIF2S2, BMP2, MAFF, PTPRR, BRCA1, TMEM100, HHEX, EDN1, TIE1]
GO:0006260;DNA replication;7.0;0.7307253602413294;0.7162820453778652;9.271849308553389;254.20053156235352;4.77312732173501;0.008507863025766288;0.5950173184638491;[CHEK1, SLBP, BLM, BARD1, CDC6, POLA1, POLA2, NASP, CDK1, FEN1, MCM7, BRCA1, CHAF1B, CHAF1A, EXO1, RFC5, RFC3, RFC4, RFC1, RFC2, RMI1, DBF4, MCM3, MCM4, MCM6, DTL, MCM2, POLD1, RBBP8, RRM1, RRM2, RPA1, DONSON, RAD50, POLE2, RPA3, DNAJA3, SSBP1]
GO:1900034;regulation of cellular response to heat;6.0;0.8653626801206646;0.7558016526504768;9.271849308553389;29.43425144606613;5.970411137910149;9.851379067933503E-4;0.6284474158353811;[CD34, RPA1, SIRT1, RPA3]
GO:0006261;DNA-dependent DNA replication;8.0;0.7586651285174919;0.754332564258746;9.318369324188282;254.89367874291247;6.250713103064308;0.008531062038107634;0.6946617587785947;[SLBP, POLD1, RFC5, RFC3, RFC4, RFC1, RFC2, RPA1, DONSON, POLE2, DNAJA3, SSBP1]
GO:0090398;cellular senescence;4.0;0.8653626801206646;0.6826813400603323;9.446202695698167;55.136139509281044;6.343086423195323;0.0018453569700716361;0.5743857346658935;[CDKN1A, PRKCD, H2AFX, HMGA1, MAPK14, SIRT1]
GO:1904354;negative regulation of telomere capping;9.0;0.9326813400603323;0.8625812952104552;9.59462270081644;613.9683692311381;7.697632086000634;0.02054896878250754;0.7898978880348613;[RAD50]
GO:0042276;error-prone translesion synthesis;10.0;1.0;0.9152410118609203;9.628524252492122;760.9157207671086;6.7325511899570465;0.025467164394386097;0.7595439928109722;[RFC5, RFC3, PCNA, RFC4, RFC1, RFC2, RPA1, POLE2, RPA3]
GO:0006303;double-strand break repair via nonhomologous end joining;9.0;0.8933024483968273;0.8428918493787028;9.548481544818586;368.8093148901945;5.8067817141283475;0.012343715862540626;0.693199712083778;[DCLRE1A, BLM, PSMD14, BRCA1, BARD1, H2AFX, MLH1, POLA1, RAD50]
GO:0045944;positive regulation of transcription by RNA polymerase II;11.0;0.5461734764479651;0.7055156905536448;8.363590748376499;1463.8556817380634;2.718315475161805;0.048993932283191266;0.5714437321440341;[EHF, PID1, SPI1, SERPINE1, SPIB, MYB, HOXA3, AKT1, HOXA2, HOXA7, HOXA5, MEF2A, MEF2C, HOXB9, HOXB4, HOXB3, HOXB2, HOXB7, ATF3, HOXB5, GATA3, GATA1, NKX2-3, JUN, JAG1, JUP, FZD5, FZD8, HOXC10, PAX5, FOS, SIRT1, PAX2, MMP12, ENG, EPCAM, STAT4, NR1H2, ATAD2, GTF2H1, POU4F1, PSMC6, PSMC2, FOSB, PF4, CCNT2, PLXND1, TNF, RUVBL2, MEN1, ADCYAP1, FOXO1, NFKB1, CXCL10, COPS5, MAFF, CIITA, CYR61, HHEX, PPP1R12A, CHUK, PEG3, TFDP1, CEBPE, NOD2, ABLIM3, E2F1, E2F2, E2F5, E2F7, PRRX1, KLF4, KLF1, KLF5, POU2AF1, CCNH, RPS6KA1, TNFSF11, DPF3, SOX4, SLC11A1, EBF1, FLT3LG, RUNX2, SFRP2, IL23A, BEX1, TWIST1, NHLH2, EGR1, EGR2, EGR3, BCL11B, LIF, CD28, TOP2A, CD40, PRL, BRCA1, CD3D, IL10, EDN1, RGMA, IL1B, TLR4, TLR2, YAP1, SATB2, LILRB1, GRHL2, CAMK1, IL17A, IHH, ARID4A, ARID4B, HOXA10, ADRB2, NLRP3, TGFB2, TGFB1, VDR, HMGA1, INHBA, NR4A2, NFKBIA, NR4A1, IL6, BMP2, NR4A3, TCF4, HMGB2, SLC40A1, ARHGEF10L, MYOCD, CKAP2, ETV1, DCN, GREM1, ELF3, TAF9, DLL1, LUM, MAPK14, MEIS2, MEIS1, RBMX]
GO:0070192;chromosome organization involved in meiotic cell cycle;5.0;0.7043150770688792;0.6423985503953599;8.567652291806858;44.78603005185074;5.682729065458369;0.0014989481210252074;0.5808560405423884;[BUB1B, SMC4, SMC2, PPP2R1A, BUB1, MLH1, RAD50, RAD51, RAD51C, CCNE2, CCNE1, FANCD2, NCAPD2, NCAPD3]
GO:0006268;DNA unwinding involved in DNA replication;8.0;0.8259837884571596;0.7879918942285797;9.34084218004034;24.41922106263308;7.57984905034425;8.172893530941673E-4;0.7626338329336335;[PURA, RAD51, MCM7, HMGA1, RPA1, MCM4, MCM6, MCM2]
GO:0006301;postreplication repair;8.0;0.8259837884571596;0.7879918942285797;9.500690880982237;183.0506323445446;5.8067817141283475;0.006126539929698291;0.6719590869034888;[PCNA, BRCA1, POLD3, POLD1, RFC5, RFC3, RFC4, RFC1, RFC2, RPA1, MSH2, POLE2, RPA3, DTL]
GO:0031619;homologous chromosome orientation involved in meiotic metaphase I plate congression;6.0;1.0;0.8231203125901445;9.628524252492122;36.661095442235386;9.777073627680469;0.0012270138716077971;0.8231203125901445;[BRCA2]
GO:0000281;mitotic cytokinesis;5.0;0.9326813400603323;0.7565816818910864;9.474373572664863;28.615093046006976;5.649939242635378;9.577214123380678E-4;0.5791791674783379;[BRCA2, CENPA, RACGAP1, STMN1, ECT2, MYH10, CEP55, PLK1, CKAP2, CIT]
GO:1990426;mitotic recombination-dependent replication fork processing;10.0;1.0;0.9152410118609203;9.628524252492122;328.81961107458824;9.083926447120524;0.011005296464229153;0.8797934328124444;[RAD51, BRCA2]
GO:0031297;replication fork processing;8.0;0.8933024483968273;0.8216512241984136;9.517298617381897;150.6515651586252;6.375876246018314;0.005042172308252987;0.701062607729944;[SMARCAL1, BLM, PCNA, BRCA2, RAD51]
GO:0071158;positive regulation of cell cycle arrest;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;83.12201169572153;5.395046993006588;0.002782018926502022;0.6268223193749;[CDKN1A, BRCA1, SOX4, TFDP1, PCNA, CCNB1, E2F1, SFN, E2F7, TGFB1, PLK2, POU4F1, FAP, CNOT3, CDK1]
GO:0016233;telomere capping;8.0;1.0;0.875;9.628524252492122;185.09737597092234;7.069023426578259;0.00619504259692348;0.7365101867784198;[RAD50]
GO:0030521;androgen receptor signaling pathway;8.0;0.8933024483968273;0.8216512241984136;9.446202695698167;54.01143535742291;5.948432231191374;0.0018077141342769656;0.6792031009335148;[TGFB1I1, FHL2, BRCA1, CCNE1, RAN]
GO:0019985;translesion synthesis;9.0;0.8933024483968273;0.8428918493787028;9.572954401337311;760.2225735865501;6.063501560976162;0.025443965382044766;0.706328376990269;[PCNA, POLD3, POLD1, RFC5, RFC3, RFC4, RFC1, RFC2, RPA1, POLE2, RPA3, DTL]
GO:0070987;error-free translesion synthesis;10.0;1.0;0.9152410118609203;9.628524252492122;760.9157207671086;6.781341354126479;0.025467164394386097;0.7620391240755716;[RFC5, RFC3, PCNA, RFC4, RFC1, RFC2, RPA1, RPA3]
GO:2000378;negative regulation of reactive oxygen species metabolic process;6.0;0.7763722522362496;0.7113064387082693;9.253830803050711;113.12708673636307;5.905872616772578;0.003786261785297929;0.6251469128630576;[HP, BRCA1, SLC30A10, CD34, IL10, CAV1, PAX2]
GO:0016579;protein deubiquitination;9.0;0.7307253602413294;0.7616033053009538;9.151600180401813;202.59641706362558;4.174954806800768;0.0067807197541817285;0.6097480081553338;[CDC20, RUVBL1, SKP2, CDC25A, CFTR, PSMD14, ADRB2, GATA3, NLRP3, BARD1, NFKBIA, COPS5, CDK1, TNFAIP3, BRCA1, PSMA5, CCNA2, PSMA6, PSMA3, PSMA4, PSMA2, FAM105A, USP1, USP9Y, PSMC6, PSMC2, EIF3F]
GO:0045717;negative regulation of fatty acid biosynthetic process;8.0;0.8436909121759173;0.7968454560879586;9.480104247373848;670.1384648150137;7.138016298065211;0.022428931331895798;0.7400384854347593;[CEACAM1, BRCA1, SIRT1]
GO:1902065;response to L-glutamate;6.0;0.9326813400603323;0.7894609826203107;9.55953138100517;96.09026658308662;7.474488534686424;0.0032160547469104574;0.7053660038532718;[PCNA, ABCB4, FYN]
GO:0000729;DNA double-strand break processing;7.0;0.811012628672052;0.7564256795932265;9.35659053700848;149.0421272461911;6.599019797332524;0.0049883058697239;0.6883935445785896;[BARD1, BLM, RAD50, EXO1, RBBP8, BRCA1]
GO:0006273;lagging strand elongation;9.0;0.9326813400603323;0.8625812952104552;9.577230958104572;265.91551950056737;7.9853141584524145;0.008899953129253659;0.8046099625986299;[POLA1, LIG1]
GO:0006271;DNA strand elongation involved in DNA replication;8.0;0.7763722522362496;0.7631861261181248;9.417215158824915;149.73527442675106;7.069023426578259;0.005011504882065279;0.7365101867784198;[POLA1, GINS2, RFC3, PCNA, RFC4, LIG1]
GO:0006272;leading strand elongation;9.0;0.9326813400603323;0.8625812952104552;9.577230958104572;265.91551950056737;8.67846133901236;0.008899953129253659;0.8400575416471059;[POLA1, PCNA]
GO:0055089;fatty acid homeostasis;7.0;1.0;0.8509193652572005;9.628524252492122;32.348635705990986;7.138016298065211;0.0010826797251974863;0.7159578506919597;[DGAT2, POLD1, SIRT1]
GO:0000724;double-strand break repair via homologous recombination;9.0;0.8653626801206646;0.8289219652406215;9.515195567185119;520.6240308586224;5.299736813202263;0.01742481778162994;0.6672694122704188;[BLM, FEN1, PSMD14, BRCA1, BRCA2, RAD54B, RBBP8, RAD54L, GINS2, H2AFX, RPA1, RAD50, RAD51, RAD51C, RPA3]
GO:0007004;telomere maintenance via telomerase;9.0;1.0;0.896240625180289;9.628524252492122;760.4775577437022;6.686031174322154;0.025452499472313803;0.7381645703673706;[RAD50, RFC1, RPA1]
GO:0000722;telomere maintenance via recombination;9.0;0.9326813400603323;0.8625812952104552;9.593432932680852;337.7230221555657;7.212124270218933;0.011303285620559713;0.7650689957573628;[RAD50, RAD51, RAD51C, BRCA2]
GO:0043137;DNA replication, removal of RNA primer;8.0;0.9326813400603323;0.8413406700301662;9.593432932680852;683.7334329296626;8.390779266560578;0.022883942680016138;0.8041048419030481;[FEN1]
GO:0007129;synapsis;6.0;1.0;0.8231203125901445;9.628524252492122;47.18392532465019;6.686031174322154;0.0015792035178401665;0.665044257777226;[CCNE2, CCNE1, FANCD2, MLH1]
GO:0001541;ovarian follicle development;4.0;1.0;0.75;9.628524252492122;34.608406302298;6.166155715036245;0.001158312213394382;0.5653374900225189;[INHBA, FANCG, ADCYAP1, KIT, CTNNA1, MMP19]
GO:0006309;apoptotic DNA fragmentation;9.0;1.0;0.896240625180289;9.628524252492122;682.1166149099336;7.004484905440688;0.022829829235937554;0.7544503089863854;[FEN1, HMGB2]
GO:0085020;protein K6-linked ubiquitination;11.0;1.0;0.9324289523296623;9.628524252492122;157.60047254366168;7.697632086000634;0.00527474598481953;0.8260862151842345;[BARD1, BRCA1]
GO:0071548;response to dexamethasone;8.0;0.9326813400603323;0.8413406700301662;9.567899630675686;124.89021324540595;6.015873511986907;0.004179963043429046;0.6826520511697386;[PCNA, FECH, ABCB4, PTAFR, FOXO1, AQP1, GHSR, EDN1, TGFB1, ARG1, IL1B]
GO:0072757;cellular response to camptothecin;7.0;1.0;0.8509193652572005;9.628524252492122;502.88914831670934;8.390779266560578;0.016831247223310163;0.7800242071602487;[BLM, RAD51]
GO:0046939;nucleotide phosphorylation;8.0;0.6729672293956388;0.7114836146978194;8.910684459341805;199.75304005510822;5.6339389012889365;0.006685554484579823;0.6631198974168686;[DTYMK, HK3, BPGM, NME1, RAD50]
GO:0006361;transcription initiation from RNA polymerase I promoter;9.0;1.0;0.896240625180289;9.628524252492122;477.15162764714074;6.311337724880743;0.015969835568764485;0.7190027299379095;[CCNH, POLR2E, POLR2K, POLR2L, GTF2H1]
GO:1902990;mitotic telomere maintenance via semi-conservative replication;9.0;1.0;0.896240625180289;9.628524252492122;232.51800064843582;8.67846133901236;0.007782168229088393;0.8400575416471059;[PCNA]
GO:0036297;interstrand cross-link repair;8.0;0.8933024483968273;0.8216512241984136;9.541512875502493;183.0506323445446;5.905872616772578;0.006126539929698291;0.6770266002729131;[DCLRE1A, FANCI, RPA1, FANCG, MSH6, RAD51, MSH2, FANCD2, RPA3]
GO:0006360;transcription by RNA polymerase I;10.0;0.9326813400603323;0.8815816818910864;9.59462270081644;583.8786478812184;7.9853141584524145;0.01954189288791682;0.8236103492792612;[GTF2H1]
GO:0006366;transcription by RNA polymerase II;10.0;0.6039883530135606;0.7172351883677006;8.613793447804714;583.8786478812184;3.2909128387363804;0.01954189288791682;0.5835384474769965;[EHF, SPI1, CCNH, SPIB, MYB, HOXA7, HOXA5, SOX4, MEF2A, MEF2C, HOXB3, HOXB2, HOXB7, ATF3, HOXB5, GATA3, GATA1, NHLH2, EGR1, EGR2, JUN, BCL11B, TGFB1I1, BRCA1, HOXC10, PAX5, FOS, SIRT1, PAX2, SATB2, FLNA, CDX2, GTF2H1, GRHL2, POU4F1, FOSB, CCNT2, ARID4A, HOXA10, C5AR1, HMGA1, NFKB1, COPS5, FEV, MAFF, MYOCD, ETV1, TFDP1, ELF3, CREB5, CEBPE, TAF9, POLR2E, POLR2I, POLR2J, POLR2K, POLR2L, PRRX1, KLF4, MEIS2, MEIS1, KLF5, POU2AF1, TAF5, RBMX]
GO:0000019;regulation of mitotic recombination;8.0;0.811012628672052;0.780506314336026;9.405380701177911;75.74767441983639;7.697632086000634;0.0025352064943508184;0.7686572628545723;[BLM, RAD50, MLH1]
GO:0006363;termination of RNA polymerase I transcription;9.0;1.0;0.896240625180289;9.628524252492122;477.15162764714074;6.343086423195323;0.015969835568764485;0.7206263598461826;[CCNH, POLR2E, POLR2K, POLR2L, GTF2H1]
GO:0006367;transcription initiation from RNA polymerase II promoter;9.0;1.0;0.896240625180289;9.628524252492122;477.15162764714074;4.629579150867016;0.015969835568764485;0.6329975182530758;[CCNH, NR3C2, CTGF, NRBP1, RUNX2, MAZ, VDR, NR4A2, NR4A1, NR4A3, TCF4, CDKN1A, MED23, YAP1, TAF9, POLR2E, E2F2, POLR2I, POLR2J, POLR2K, POLR2L, NR1H2, GTF2H1, TAF5]
GO:0006368;transcription elongation from RNA polymerase II promoter;9.0;1.0;0.896240625180289;9.628524252492122;477.15162764714074;5.459585514144159;0.015969835568764485;0.675444082270312;[CCNT2, CCNH, POLR2E, POLR2I, POLR2J, POLR2K, POLR2L, GTF2H1, ELP4]
GO:0043150;DNA synthesis involved in double-strand break repair via homologous recombination;9.0;1.0;0.896240625180289;9.628524252492122;576.4787940614489;9.777073627680469;0.019294226440005207;0.896240625180289;[BRCA2]
GO:0031954;positive regulation of protein autophosphorylation;10.0;0.9326813400603323;0.8815816818910864;9.59573442966913;778.6672313762616;6.481236761676141;0.026061291479152104;0.7466917612613706;[ACE, SYK, PDGFA, GREM1, RAD50, GPNMB, PDGFD, PDGFC]
GO:0031398;positive regulation of protein ubiquitination;10.0;0.7508913569872202;0.7906866903545304;9.372590878354922;528.4459358446122;5.113634533568402;0.01768660990225356;0.6767525197159333;[LRRK2, PTPN22, BRCA1, BMI1, CDC20, SKP2, ADRB2, NOD2, FANCI, NDFIP2, WFS1, UBE2C, CAV1, PLK1]
GO:0072425;signal transduction involved in G2 DNA damage checkpoint;9.0;0.9326813400603323;0.8625812952104552;9.590783924509275;196.6208089386036;7.292166977892469;0.006580721527935406;0.769162383550154;[CHEK1, PLK1, BRCA1, DTL]
GO:0010575;positive regulation of vascular endothelial growth factor production;6.0;1.0;0.8231203125901445;9.628524252492122;64.54350789155374;6.481236761676141;0.002160213123744424;0.6545710619905948;[TGFB1, C5AR1, BRCA1, PTGS2, SULF1, SULF2, IL1B, C3AR1, CYP1B1, HPSE]
GO:0045739;positive regulation of DNA repair;8.0;0.7671156992804218;0.7585578496402109;9.360260265897443;499.6181899148078;5.8650506222523235;0.01672177118926996;0.6749389615747303;[BLM, PCNA, BRCA1, H2AFX, SIRT1]
GO:0090305;nucleic acid phosphodiester bond hydrolysis;6.0;0.6073376606709605;0.6267891429256247;8.355558576679234;112.24841944109592;4.100319825412187;0.0037568535816745637;0.5328108591460956;[DCLRE1A, POP5, RNASE6, RNASE3, RNASE2, ERI2, FEN1, HMGB2, EXO1, RFC5, RFC3, RFC4, RFC1, RFC2, PCNA, SAMHD1, POLD3, POLD1, RBBP8, POLR2I, RPA1, GTF2H1, RAD50, RPA3]
GO:0000707;meiotic DNA recombinase assembly;8.0;0.8259837884571596;0.7879918942285797;9.405380701177911;133.9647452985807;7.697632086000634;0.004483679464700174;0.7686572628545723;[RAD51, RAD51C]
GO:0006370;7-methylguanosine mRNA capping;10.0;1.0;0.9152410118609203;9.628524252492122;354.47150569988446;6.250713103064308;0.011863842292131473;0.734902770639515;[CCNH, POLR2E, POLR2I, POLR2J, POLR2K, POLR2L, GTF2H1]
GO:0030855;epithelial cell differentiation;4.0;0.5489353771682173;0.5244676885841086;6.961296045910167;21.066225782797595;4.034070439870987;7.050676185779127E-4;0.45630254989846264;[EHF, LGALS3, BASP1, AKT1, HOXA5, SOX4, MEN1, MEF2C, EREG, COL4A1, ADAM9, HOXB5, EPHA2, GATA3, PSAP, FZD1, ST14, JUN, TGFB1, JAG1, BMP2, CDK1, CD24, TGFB1I1, SLC7A11, TMEM100, HHEX, LBH, CD34, CTSB, DSP, ANXA1, PAX2, GREM1, ELF3, YAP1, TAGLN, PCNA, E2F7, CDX2, KLF4, USH2A, GRHL2]
GO:0071681;cellular response to indole-3-methanol;6.0;1.0;0.8231203125901445;9.628524252492122;467.4090985487011;8.16763571524637;0.01564376188754665;0.7408135829017477;[JUP, CDH1, CTNNA1, BRCA1]
GO:0051574;positive regulation of histone H3-K9 methylation;11.0;0.8933024483968273;0.8790801765280758;9.571365838652174;804.3299673530898;7.474488534686424;0.02692020015733362;0.8146746435927894;[MYB, BRCA1, SIRT1]
GO:0051572;negative regulation of histone H3-K4 methylation;11.0;0.9326813400603323;0.8987696223598284;9.59953671561887;804.8473500351352;8.390779266560578;0.026937516490087493;0.8615337942327104;[BRCA1]
GO:0051573;negative regulation of histone H3-K9 methylation;11.0;0.8933024483968273;0.8790801765280758;9.571365838652174;805.1350321075869;7.57984905034425;0.026947144950155395;0.8200627852632958;[PAX5, BRCA1, SIRT1]
GO:0051571;positive regulation of histone H3-K4 methylation;11.0;0.9326813400603323;0.8987696223598284;9.59953671561887;804.0422852806381;7.004484905440688;0.026910571697265715;0.7906386361357586;[MYB, BRCA1]
GO:0032355;response to estradiol;5.0;0.9326813400603323;0.7565816818910864;9.523163736834295;74.25476231829794;4.940791720728991;0.0024852400698459885;0.542913330229313;[IHH, BRCA2, CTGF, RUVBL2, PDGFRB, IL10, GHSR, ANXA1, DUSP1, TACR3, CCNA2, IL1B, PCNA, ABCB4, PTGS2, SOCS2, RBBP8, TGFB1, NR2F2, POU4F1, COL1A1, GH1, CD4, KIF18A, EZH2]
GO:0070512;positive regulation of histone H4-K20 methylation;11.0;1.0;0.9324289523296623;9.628524252492122;803.63682017253;9.777073627680469;0.02689700114499224;0.9324289523296623;[BRCA1]
GO:0070911;global genome nucleotide-excision repair;9.0;1.0;0.896240625180289;9.628524252492122;184.43692670566384;6.518977089658987;0.006172937954381027;0.7296214167088868;[GTF2H1]
GO:0016567;protein ubiquitination;9.0;0.6913464685778243;0.7419138594692012;8.996001693748612;153.79381005389072;3.300101264790787;0.005147340417060716;0.5650079573320931;[AKT1, CDCA3, BARD1, HACE1, PLK1, SIRT1, FBXW2, CUL5, SOCS2, MARCH3, MARCH1, BIRC5, DTL, NLRC4, RNF24, CDC20, SKP2, NAIP, BRCA1, BMI1, RNF144B, PDZRN3, PCNA, KLHL14, UBE2C, UBE2M, TNFAIP3, HIST1H2BK]
GO:0033600;negative regulation of mammary gland epithelial cell proliferation;7.0;1.0;0.8509193652572005;9.628524252492122;170.73536782227262;8.390779266560578;0.005714359109156348;0.7800242071602487;[GATA3, BRCA2, PHB2]
GO:1903461;Okazaki fragment processing involved in mitotic DNA replication;8.0;1.0;0.875;9.628524252492122;164.54098766952777;9.777073627680469;0.005507038780024182;0.875;[LIG1]
GO:0043967;histone H4 acetylation;12.0;0.8259837884571596;0.8611122068187244;9.464221201200845;659.4528027923784;5.825829909099042;0.022071291840469662;0.7460535250702665;[BRCA2, RUVBL2, RUVBL1, ELP4]
GO:0035067;negative regulation of histone acetylation;11.0;0.811012628672052;0.8379352666656883;9.498471124243924;1304.334881216342;6.943860283624253;0.04365491464912905;0.7875382901567328;[SPI1, TWIST1, BRCA1, SIRT1, SNCA]
GO:0043966;histone H3 acetylation;12.0;0.7671156992804218;0.8316781622303555;9.3498108500231;659.4528027923784;5.926926025970411;0.022071291840469662;0.7512235851885185;[SPI1, TAF9, ELP4, BRCA2]
GO:0044818;mitotic G2/M transition checkpoint;10.0;0.8933024483968273;0.861892236059334;9.551563211355994;492.819650181817;6.343086423195323;0.016494230182695288;0.7396267465268138;[FANCI, BLM, DONSON, CDC6, BRCA1, MSH6, CDK1, TOPBP1, NAE1]
GO:0032077;positive regulation of deoxyribonuclease activity;8.0;0.8933024483968273;0.8216512241984136;9.55953138100517;813.6405734422207;8.16763571524637;0.027231817764135358;0.7926932703116032;[PCNA, PRKCD, AKT1]
GO:0045589;regulation of regulatory T cell differentiation;9.0;0.7866048967936545;0.7895430735771163;9.517298617381897;133.46855707074621;6.518977089658987;0.004467072491254967;0.7296214167088868;[TGFB1, CR1, LILRB2, DUSP10, BCL6, IFNG, FANCD2, CD28, CTLA4]
GO:0045740;positive regulation of DNA replication;8.0;0.7671156992804218;0.7585578496402109;9.427853557029971;747.3070825002359;6.166155715036245;0.025011695518573164;0.6903374900225189;[JUN, PCNA, EREG, DBF4, CDK1, E2F7]
GO:0006342;chromatin silencing;11.0;0.7763722522362496;0.820615078447787;9.454170865347344;1752.5176526080036;5.433268205826786;0.058655188669300654;0.7102865410484548;[SUV39H1, BMI1, H2AFX, SIRT1]
GO:0000079;regulation of cyclin-dependent protein serine/threonine kinase activity;11.0;0.7866048967936545;0.8257314007264895;9.474373572664863;340.6851601099881;5.181953777545879;0.011402425712143147;0.6974343094988531;[CDKN1A, CCNT2, CCNH, TNFAIP3, HHEX, AKT1, MEN1, MYOCD, CDC25A, CCNA2, PSRC1, CCNE2, CCNE1, CKS2, BLM, PKMYT1, CCNB2, CCNB1, SFN, CDKN2C, PLK1, GTF2H1, CDC6, NR2F2]
GO:0051103;DNA ligation involved in DNA repair;8.0;0.9326813400603323;0.8413406700301662;9.571365838652174;150.14073953485922;7.292166977892469;0.005025075434338753;0.747921758369865;[LIG1, HMGB2]
GO:0006978;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;8.0;1.0;0.875;9.628524252492122;145.46952913610525;7.004484905440688;0.004868734226108882;0.7332096838060964;[CDKN1A, BRCA1, BRCA2]
GO:2000617;positive regulation of histone H3-K9 acetylation;12.0;1.0;0.9481203125901445;9.628524252492122;1488.212472397538;7.8311634786251565;0.049809132146875434;0.8486063770733797;[GATA3, BRCA1]
GO:0097421;liver regeneration;6.0;1.0;0.8231203125901445;9.628524252492122;47.21654787453615;6.250713103064308;0.0015802953652264606;0.6427820713687392;[IL10, PCNA, TGFB1, IHH, SULF2, NFKBIA, HMOX1, EZH2]
GO:0006977;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;11.0;1.0;0.9324289523296623;9.628524252492122;888.119660647831;5.75172193694532;0.0297245657860804;0.7265722796674696;[CDKN1A, PCNA, CCNB1, E2F1, SFN, E2F7, SOX4, PLK2, TFDP1, CNOT3, CDK1]
GO:0000083;regulation of transcription involved in G1/S transition of mitotic cell cycle;10.0;0.8933024483968273;0.861892236059334;9.541512875502493;264.067998117236;6.444869117505266;0.008838118251214853;0.7448319182472036;[PCNA, RRM2, CDC6, POLA1, TFDP1, CCNE1, E2F1, FBXO5, E2F7]
GO:0032508;DNA duplex unwinding;7.0;0.7980440201809971;0.7499413753476991;9.223059144383958;23.726073882073138;5.734022359845919;7.940903407527885E-4;0.64415753539903;[BLM, MCM7, RAD54B, PURA, RUVBL2, RUVBL1, GINS2, ANXA1, HMGA1, RPA1, RAD50, RAD51, MCM4, MCM6, MCM2]
GO:0000082;G1/S transition of mitotic cell cycle;5.0;1.0;0.7902410118609202;9.628524252492122;42.752976916212816;5.142344639450834;0.0014309036622044387;0.5532207558659172;[CDKN1A, MCM7, GMNN, SKP2, CDC25A, DBF4, CCNE2, CCNE1, MCM3, MCM4, RHOU, MCM6, BCAT1, MCM2, CUL5, PRIM1, IQGAP3, RBBP8, RANBP2, RANBP1, CDKN2C, PLK2, RPA1, CDC6, INHBA, POLA1, POLA2, WEE1, NASP, POLE2, RPA3]
GO:0034644;cellular response to UV;7.0;0.7980440201809971;0.7499413753476991;9.223059144383958;66.19362175939281;5.420364800990877;0.0022154409498949313;0.628117073252615;[CDKN1A, FMR1, PTPRK, AQP1, RUVBL2, CHEK1, MME, SIRT1, CDC25A, PCNA, PTGS2, AURKB, POLD1, EIF2S1, MFAP4]
GO:0032465;regulation of cytokinesis;6.0;0.5930994877375815;0.6196700564589352;8.140447197062288;31.798591743249187;5.358233019883872;0.0010642702487719462;0.5971405984103235;[AHCTF1, BRCA2, NUP62, PRKCE, TAS2R13, CIT, CXCR5, AURKB, RACGAP1, ECT2, E2F7, SVIL, PLK1, CDC6, PRC1]
GO:0071479;cellular response to ionizing radiation;6.0;0.8933024483968273;0.7697715367885581;9.446202695698167;48.660440229648614;5.602686357784832;0.0016286211429333208;0.6096419534788213;[YAP1, CDKN1A, BLM, FIGNL1, ECT2, EGR1, TGFB1, H2AFX, MAPK14, SIRT1, DNM2, RAD51, SFRP2, NOX4]
GO:0071356;cellular response to tumor necrosis factor;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;4.973052582947213;0.0027327542132076126;0.5774424529526606;[PID1, BRCA1, PYCARD, TCL1A, AKT1, EDN1, CHUK, SIRT1, CHI3L1, XCL1, CCL13, CALCA, GATA3, ADAMTS12, THBS1, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, CD58, CCL19, CCL18, CCL23, VCAM1, CCL21, CCL20, MAPK14, NFKB1, COL1A1]
GO:0033674;positive regulation of kinase activity;9.0;0.6073376606709605;0.6999094555157693;8.620883742029738;265.89784403492143;3.4106031799490317;0.008899361547325376;0.5706590304121504;[, IL1RN, CCNH, TCL1A, AKT1, PROK2, TNFSF11, EPHB2, EPHB1, PRKACB, ACSL1, SLC11A1, PRKCD, MIF, EREG, PRKAR1B, IL23A, EPHA3, EPHA2, FPR1, TGFA, PDGFA, FPR2, IQGAP3, PRKAR2B, PDGFD, PDGFC, S100A12, NCKAP1L, ELANE, LYN, EGR1, ACE, FZD5, FZD8, CDC6, AZU1, PTK2, NOX4, CD24, EZH2, CDKN1A, CD40, CCR7, MAP4K1, EDN1, SYK, SIRT1, DUSP6, MDFIC, IL1B, KIT, CKS2, TLR6, TLR4, CXCR4, PAK1, NTF3, CCL19, CCL21, CENPE, CD40LG, PKN1, CAMK1, CCNT2, TNF, CLU, IL6R, PDGFRB, PDGFRA, MAP2K2, F2R, ADCYAP1, ADAM9, CSF1R, CALCA, C5AR1, TNFRSF11A, ADRB2, CCNB1, STAP1, ECT2, DRD4, MAP2K6, TGFB2, TGFB1, TNFRSF10B, GH1, BMP2, PTPRC, CDK1, CSPG4, LAT, LRRK2, ITGB3, CYR61, GHR, GRM5, FGR, GREM1, PSRC1, IFNG, CHI3L1, LCP2, PDE5A, LTF, NOD2, THBS1, CCL5, FYN, CSK, SNCA, EGF, TIE1, MAPK14, CD4, RAD50, TEK]
GO:0010833;telomere maintenance via telomere lengthening;8.0;0.9326813400603323;0.8413406700301662;9.590783924509275;185.09737597092234;6.409777797693995;0.00619504259692348;0.7027963346592216;[RFC1, RPA1, RAD50, RAD51]
GO:0070301;cellular response to hydrogen peroxide;6.0;1.0;0.8231203125901445;9.628524252492122;361.02555909653125;5.682729065458369;0.012083200561052132;0.6137353412716126;[PCNA, TNFAIP3, FOXO1, AQP1, IL18RAP, PDGFD, MYB, CYP1B1, ECT2, ANXA1, ARG1, PRKCD, KLF4, SIRT1, PAX2, IL6, CDK1, EZH2]
GO:0051865;protein autoubiquitination;10.0;1.0;0.9152410118609203;9.628524252492122;155.4032479663248;5.769740442447999;0.005201206855589802;0.7103058064080809;[BRCA1]
GO:0051106;positive regulation of DNA ligation;8.0;0.9326813400603323;0.8413406700301662;9.57973408832269;378.6008333431687;8.16763571524637;0.012671429173367173;0.7926932703116032;[RAD51]
GO:0070816;phosphorylation of RNA polymerase II C-terminal domain;11.0;0.811012628672052;0.8379352666656883;9.52844079393514;433.3999751397635;7.8311634786251565;0.014505507133273452;0.8329150168128974;[GTF2H1]
GO:0042769;DNA damage response, detection of DNA damage;5.0;0.7866048967936545;0.6835434602577475;9.143016436710422;39.83823472227698;6.139487467954083;0.0013333498640710748;0.6042146864874571;[PCNA, POLD3, POLD1, USP1, SOX4, RFC5, RFC3, RFC4, RFC1, RFC2, RPA1, RPA3, DTL]
GO:0007286;spermatid development;5.0;1.0;0.7902410118609202;9.628524252492122;72.7828096339012;5.370354380416217;0.0024359751381706407;0.5648811846224242;[JAM3, FANCG, KIT]
GO:0046600;negative regulation of centriole replication;11.0;0.9326813400603323;0.8987696223598284;9.590783924509275;466.4695881312043;7.697632086000634;0.015612317319377515;0.8260862151842345;[BRCA1]
GO:0006633;fatty acid biosynthetic process;8.0;0.6493065804076676;0.6996532902038338;8.912904216080118;359.8485513982277;5.076593261888053;0.01204380717262807;0.6346172154986847;[TECR, BRCA1, EDN1, ELOVL4, ELOVL6, MIF, ELOVL7, MGST1, PTGS2, CYP3A4, PTGS1, ALOX5, PNPLA8, SCD, NDUFAB1, PLP1]
GO:0006359;regulation of transcription by RNA polymerase III;10.0;0.8436909121759173;0.837086467948879;9.52844079393514;248.56913769389934;6.481236761676141;0.008319385340914571;0.7466917612613706;[BRCA1, BDP1]
GO:0007569;cell aging;3.0;0.7980440201809971;0.597142322680643;8.935377071932177;24.751975343904395;5.618190544320798;8.284263394289076E-4;0.485434838299289;[CDKN1A, SERPINE1, BRCA2, NUP62, CHEK1, MME, PRKCD, H2AFX, HMGA1, MIF, MAPK14, SIRT1, DNAJA3, CDK1, NOX4, ENG]
GO:0045876;positive regulation of sister chromatid cohesion;9.0;0.7436939687323844;0.7680876095464813;9.292052015870908;259.00348872071737;7.474488534686424;0.008668613679475917;0.7784863164434164;[FEN1]
GO:0051598;meiotic recombination checkpoint;9.0;1.0;0.896240625180289;9.628524252492122;404.9258988516973;8.390779266560578;0.01355250542491682;0.8253454670833372;[BRCA2]
GO:0006349;regulation of gene expression by genetic imprinting;7.0;0.8933024483968273;0.7975705894556142;9.577230958104572;130.9317736178294;6.8867018697843045;0.004382168632042727;0.7031056191423581;[KCNQ1, ARID4A, ARID4B, BRCA1]
GO:0044030;regulation of DNA methylation;7.0;0.7980440201809971;0.7499413753476991;9.253830803050711;73.34977914704017;6.7325511899570465;0.0024549510975359675;0.6952223462072524;[SPI1, BRCA1, GRHL2]
GO:0048478;replication fork protection;10.0;1.0;0.9152410118609203;9.628524252492122;1135.309178205509;7.57984905034425;0.037997776482613155;0.8028748447945538;[SMARCAL1, BLM, DONSON, BRCA2]
GO:2000620;positive regulation of histone H4-K16 acetylation;13.0;1.0;0.9625549647676366;9.628524252492122;1673.9769773112196;9.083926447120524;0.056026502949136;0.9271073857191605;[BRCA1]
GO:0033147;negative regulation of intracellular estrogen receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;234.23542340630428;7.138016298065211;0.007839648823214116;0.7400384854347593;[LBH, BRCA1, PHB2]
GO:0034599;cellular response to oxidative stress;4.0;0.7248374789738407;0.6124187394869203;8.935377071932177;68.67201153720991;4.519578255652688;0.0022983904253524798;0.48113144217596127;[AQP1, IL18RAP, MYB, AKT1, CYP1B1, PDGFRA, DAPK1, TPM1, PRKCD, FANCD2, BTK, MGST1, FOXO1, PDGFD, ECT2, JUN, EIF2S1, NR4A2, IL6, CDK1, NOX4, EZH2, LRRK2, TNFAIP3, PTPRK, CD36, ANXA1, CHUK, ARG1, FOS, MMP9, SIRT1, PAX2, DNM2, CCNA2, PCNA, SNCA, KLF4]
GO:0010569;regulation of double-strand break repair via homologous recombination;9.0;0.8436909121759173;0.8180860812682478;9.523163736834295;184.48234756552796;6.221725566191056;0.00617445814968456;0.7144199599751273;[BLM, RAD51, FIGNL1, CHEK1]
GO:2000348;regulation of CD40 signaling pathway;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;41.8512380110395;7.9853141584524145;0.0014007232725606145;0.7314896500084853;[FANCD2, TNFAIP3, TREM2]
